上海市内分泌代谢病研究所于1979年成立，全额拨款事业单位，上级主管单位为上海交通大学医学院。本研究所的职责为从事于临床医学的基础研究，开展高水平科学研究，培养高等级医学人才，为防病治病服务。目前本研究所已形成了较强的学科、基地、团队等综合优势，承担了一批国家级科研项目，获得了一批科研成果，培养了一批高水平人才，集聚了一批优秀的中青年学者。为国家临床医学研究中心的基础研究基地、国家重点学科、上海市一流学科、卫生部内分泌代谢病重点实验室、上海市重点实验室，承办的两本学术期刊，《中华内分泌代谢杂志》为受中华医学会的委托承办的国内学术影响力最高的内分泌代谢学术期刊，《Journal of Diabetes》为国内唯一被SCI收录的学术期刊（影响因子为2.4949）。临床内分泌实验室为国内唯一通过美国病理家协会（CAP）认证的内分泌专业实验室。
本研究所现已形成以转化型医学为理念的内分泌代谢病系统生物学研究体系，在凝练为遗传性内分泌代谢病临床诊治以及慢性非传染性代谢病发病机制、流行病学研究两大方向的同时，重点建设内分泌代谢病临床诊治、预防、预警和研发体系。该体系进一步依托专业化的临床研究公共服务平台和协同研究网络，致力于开展大规模、前瞻性、多中心、高质量的临床诊疗规范研究。本研究所已形成一支梯队层次合理，团结奋进，朝气蓬勃，极富创新能力的团队。建所以来承担各级各类课题203项，到位经费总计13285.65万元；其中国家级课题150项，到位经费总计11732.03万元。发表SCI收录学术论文211篇，总分714分，总被引次数2293次；其中5分以上论文44篇，总分324.177分；获国家科技进步二等奖3次, 国家自然科学奖二等奖一次；已获授权专利12项。建成国际上单中心最大的450万份生物样本库。
本研究所事业编制55人，目前在编在职职工39人。目前已形成实力较强的学术梯队，拥有国内外知名的内分泌专家，有较高的学术地位。本所目前有正高级职称4人、副高级职称9人、中级职称22人；其中博士21人，硕士5人；在读研究生72人。
学科带头人为宁光，中国工程院院士，973首席科学家，长江学者特聘教授。上海交通大学医学院附属瑞金医院副院长，卫生部内分泌代谢重点实验室主任，国家代谢性疾病临床医学研究中心主任，中华医学会内分泌学分会前任主委，中国医师协会内分泌代谢科医师分会会长，《中华内分泌代谢杂志》总编辑。长期从事内分泌代谢病临床与科研工作，在遗传性内分泌疾病、肾上腺疾病与糖尿病临床诊治取得丰硕成果，三次获得国家科技进步二等奖。
《中华内分泌代谢杂志》（CJEM）是上海市内分泌代谢病研究所受中华医学会委托编辑出版的、反映我国当代内分泌代谢领域最新临床及基础研究成果的高端学术刊物。CJEM曾获中国科协优秀期刊奖，多次被评为中华医学会优秀期刊，现任总编宁光教授。本杂志在办刊过程中坚持学术为重，逐步形成了自身的特色。本杂志在国际上已为Chemical Abstract（CA）、TOXCENTER、西太平洋区医学索引（WPRIM）所收录。国内为VIP、CNKI、CAJCED、CSCD、CJFD、中国核心期刊（遴选）等数据库收录。2014年9月26日，中国科学技术信息研究所在京召开“中国科技论文统计结果发布会”，《中华内分泌代谢杂志》入围第三届中国精品科技期刊和国际化精品科技期刊（共300种），并且综合评价总分位列“内分泌病学与代谢病学、风湿病学类”学科第一名。本杂志自第一届以来连续三次入围中国精品科技期刊和国际化精品科技期刊，并且连续三次位列本学科第一名。
《Journal of Diabetes》是由本研究所与国际著名期刊出版集团Wiley-Blackwell于2009年联合创办，宁光教授和美国Mount Sinai医学院Zachary Bloomgarden教授为共同主编，并获中华医学会内分泌学分会和中国医师协会内分泌代谢科医师分会支持。《Journal of Diabetes》是中国第一本专注于糖尿病的国际英文期刊，是东西方专家共同合作的结晶，致力于将中国糖尿病医生和研究者的最新成果介绍给国际糖尿病学界，同时及时将国际最新研究成果介绍给国内，促进糖尿病研究的进一步发展。2013年7月，《Journal of Diabetes》的首个影响因子发布，达2.939，这是继2010年6月被MEDLINE收录以来，本刊所取得的又一个里程碑式的进步。
为响应国家“十三五”规划，本研究所将加强医学科技创新体系建设，努力将自身打造为临床医学和转化研究的高地，在运行机制、思维方式及观念、临床诊疗技术和科研思路和方法等方面按照国际通行的运作方式运作，成为一开放的、创新的、充满活力的研究所，从而能把握国际内分泌学的发展潮流，建立自身的特色，成为具有自身特点的可参与国际竞争的临床医学科研机构。
Shanghai Institute of Endocrine and Metabolic Diseases
The Shanghai Institute of Endocrine and Metabolic Diseases was established in 1979. It allocates full funds to public institutions. The higher authorities are the Medical College of Shanghai Jiaotong University. The responsibility of this institute is to engage in basic research of clinical medicine, carry out high-level scientific research, train high-level medical talents, and serve for disease prevention and treatment. At present, the Institute has formed a strong comprehensive advantage of disciplines, bases and teams, undertook a number of national scientific research projects, obtained a number of scientific research results, trained a number of high-level talents, and gathered a number of outstanding young and middle-aged scholars. For the basic research base of the National Clinical Medical Research Center, the key disciplines of the State, the first-class disciplines of Shanghai, the Key Laboratory of Endocrine and Metabolic Diseases of the Ministry of Health and the Key Laboratory of Shanghai, the two academic journals are sponsored by the State Clinical Medical Research Center. The Chinese Journal of Endocrine Metabolism is the most influential academic journal of endocrine and metabolism in China entrusted by the Chinese Medical Association. Diabetes is the only academic journal included by SCI in China (the impact factor is 2.4949). Clinical Endocrinology Laboratory is the only professional endocrinology laboratory in China that has passed the certification of American Pathologists Association (CAP).
The Institute has developed a system of systemic biology of endocrine and metabolic diseases based on transformational medicine. While concreting the two directions of clinical diagnosis and treatment of hereditary endocrine and metabolic diseases, as well as the pathogenesis and epidemiology of chronic non-infectious metabolic diseases, the Institute focuses on the construction of a system of clinical diagnosis, prevention, early warning and research of endocrine and metabolic diseases. The system further relies on the specialized public service platform for clinical research and the collaborative research network to carry out large-scale, prospective, multi-center, high-quality clinical diagnosis and treatment normative research. This Research Institute has formed a team with reasonable echelon levels, united and striving, vigorous and innovative ability. The Institute undertakes 203 projects at all levels, totaling 1328.655 million yuan, of which 150 are at the national level, totaling 117.3203 million yuan. SCI published 211 academic papers, with a total score of 714 and 2293 citations; 44 papers with more than 5 points, with a total score of 324.177; 3 second-class prizes for national scientific and technological progress and one second-class prize for national natural science; 12 patents have been authorized. Build the largest 4.5 million biological sample bank of single center in the world.
The Institute has 55 employees and 39 employees. At present, it has formed a strong academic echelon, with well-known endocrinologists at home and abroad, and has a high academic status. At present, the Institute has 4 senior titles, 9 vice senior titles and 22 intermediate titles, including 21 doctors and 5 masters, and 72 postgraduates.
The subject leader is Ningguang, academician of Chinese Academy of Engineering, chief scientist of 973, specially appointed professor of Yangtze River scholars. Deputy Dean of Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University, Director of Key Laboratory of Endocrinology and Metabolism, Ministry of Health, Director of National Center for Clinical Medicine of Metabolic Diseases, Former Chairman of Endocrinology Society of Chinese Medical Association, President of Endocrinology and Metabolism Branch of Chinese Medical Association, Editor-in-chief of Chinese Journal of Endocrinology and Metabolism. He has been engaged in clinical and scientific research of endocrine and metabolic diseases for a long time, and has made great achievements in the diagnosis and treatment of hereditary endocrine diseases, adrenal diseases and diabetes mellitus. He has won the second prize of national scientific and technological progress three times.
The Chinese Journal of Endocrinology and Metabolism (CJEM) is a high-end academic journal authorized by the Shanghai Institute of Endocrinology and Metabolism Diseases by the Chinese Medical Association, which reflects the latest clinical and basic research results in the field of endocrine and metabolism in contemporary China. CJEM has been awarded the Excellent Journal Award of the Chinese Association of Sciences, and has been awarded the Excellent Journal of the Chinese Medical Association for many times. He is currently Professor Ning Guang, Editor-in-Chief. In the process of running the magazine, the magazine adheres to the importance of academics and gradually forms its own characteristics. This magazine has been included in Chemical Extract (CA), TOXCENTER and Western Pacific Medical Index (WPRIM). It is included in VIP, CNKI, CAJCED, CSCD, CJFD, China's core journals (selection) and other databases. On September 26, 2014, the Chinese Institute of Scientific and Technological Information held a "Statistical Result Conference of Chinese Scientific and Technological Papers" in Beijing. The Chinese Journal of Endocrinology and Metabolism was selected as the third Chinese Quality Science and Technology Journal and the international Top Quality Science and Technology Journal (a total of 300 kinds). The comprehensive evaluation ranked first in the subjects of "Endocrinology and Metabolism, Rheumatology". Since its first edition, the magazine has been listed in three consecutive Chinese and international high-quality sci-tech journals, and ranked first in the discipline for three consecutive times.
Journal of Diabetes was co-founded by the Institute and Wiley-Blackwell, a well-known international journal publishing group, in 2009. Professor Ningguang and Professor Zachary Bloomgarden of Mount Sinai Medical College in the United States were co-editors, and supported by the Endocrinology Society of the Chinese Medical Association and the Endocrinology and Metabolism Medical Association of the Chinese Medical Association. Journal of Diabetes is the first international English journal focusing on diabetes in China. It is the result of the cooperation of experts from the East and the West. It is committed to introducing the latest achievements of Chinese diabetes doctors and researchers to the International Diabetes academia. At the same time, it timely introduces the latest international research results to China and promotes the further development of diabetes research. In July 2013, the first influencing factor of Journal of Diabetes was released, reaching 2.939, which is another milestone since it was included in MEDLINE in June 2010.
In response to the 13th Five-Year Plan, the Institute will strengthen the construction of medical science and technology innovation system, strive to build itself into a plateau of clinical medicine and transformational research, and operate in accordance with the international operation mode in terms of operation mechanism, mode of thinking and concept, clinical diagnosis and treatment technology and scientific research ideas and methods, so as to become an open, innovative and energetic research institute. In this way, we can grasp the development trend of international endocrinology, establish our own characteristics, and become a clinical medical research institution with its own characteristics that can participate in international competition.
